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AbstrAct
Introduction In-bed cycling with patients with critical 
illness has been shown to be safe and feasible, and 
improves physical function outcomes at hospital discharge. 
The effects of early in-bed cycling on reducing the rate of 
skeletal muscle atrophy, and associations with physical 
and cognitive function are unknown.
Methods and analysis A single-centre randomised 
controlled trial in a mixed medical-surgical intensive 
care unit (ICU) will be conducted. Adult patients (n=68) 
who are expected to be mechanically ventilated for more 
than 48 hours and remain in ICU for a further 48 hours 
from recruitment will be randomly allocated into either 
(1) a usual care group or (2) a group that receives usual 
care and additional in-bed cycling sessions. The primary 
outcome is change in rectus femoris cross-sectional 
area at day 10 in comparison to baseline measured by 
blinded assessors. Secondary outcome measures include 
muscle strength, incidence of ICU-acquired weakness, 
handgrip strength, time to achieve functional milestones 
(sitting out of bed, walking), Functional Status Score in 
ICU, ICU Mobility Scale, 6 min walk test 1 week post-
ICU discharge, incidence of delirium and quality of life 
(EuroQol Five Dimensions questionnaire Five Levels 
scale). Quality of life assessments will be conducted 
post-ICU admission at day 10, 3 and 6 months after 
acute hospital discharge. Participants in the intervention 
group will complete an acceptability of intervention 
questionnaire.
Ethics and dissemination Appropriate ethical approval 
from Metro South Health Human Research Ethics 
Committee has been attained. Results will be published 
in peer-reviewed publications and presented at scientific 
conferences to assist planning of future multicentre 
randomised controlled trials (if indicated) that will test 
in-bed cycling as an intervention to improve the physical, 
cognitive and health-related quality of life outcomes of 
patients with critical illness.
trial registration number This trial has been 
prospectively registered on the Australian and New 
Zealand Clinical Trial Registry (ACTRN12616000948493); 
Pre-results.
bAckground And rAtIonAlE
Patients with critical illness often require 
mechanical ventilation for periods greater 
than 48 hours. It has been identified that skel-
etal muscle wasting occurs early and rapidly 
during the first week of critical illness.1 
Despite international recommendations for 
patients with critical illness to commence 
activity as early as possible,2 it has been iden-
tified that exercise interventions are rarely 
initiated when a patient is on mechanical 
ventilation.3 This leads to prolonged immo-
bility and may contribute to the development 
of intensive care unit-acquired weakness 
(ICUAW).4 In-bed cycling using a cycle ergom-
eter has been proposed as a safe and feasible 
method of introducing early exercise for 
patients with critical illness on mechanical 
ventilation who are sedated and immobile, 
this includes patients requiring inotropic 
support.5–7 In-bed cycling may also assist in 
the preservation of muscle architecture. To 
date, only one randomised controlled trial 
(RCT) utilising in-bed cycling in the crit-
ically ill population has been published.8 
This single-centre RCT (n=90) conducted in 
Belgium found in-bed cycling to be safe for 
patients with critical illness and to improve 
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Protocol
strengths and limitations of this study
 ► The randomised trial design with blinded 
assessments of skeletal muscle size, strength and 
function to provide objective measures of difference.
 ► The inclusion of an acceptability questionnaire 
will provide useful insights for subsequent 
implementation (if indicated).
 ► The study may not be powered for all secondary 
outcomes, and evidence of effect size from pilot 
data is not available for those measures.
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their 6 min walk distance, quadriceps force and Short 
Form-36 physical function scores on hospital discharge.8 
A limitation of this study was that the effects of the inter-
vention at the muscular level were not assessed with 
muscle biopsy or ultrasound.8 A pilot case-matched study 
of in-bed functional electrical stimulated cycling inter-
vention in addition to usual care found positive physical 
outcomes observed among the cycling group including 
less time required to achieve functional milestones, 
time to stand and time to ambulate independently.9 In 
addition, a shorter duration of delirium among those 
who participated in the functional electrical stimulation 
(FES) in-bed cycling intervention was observed.9 
A recent clinical trial has demonstrated that patients 
with critical illness may experience persistent weakness 
despite participating in intensive exercise programmes 
while they are critically ill.10 It has been suggested that 
intensive exercise programmes may not be effective if 
the commencement of these programmes is delayed.11 
Early exercise commencement is intended to assist in 
the maintenance of muscle mass. This may be achieved 
through a moderation of the inflammatory process.11 
Consequently, the effectiveness of exercise interventions 
that can commence early during critical illness are neces-
sary to demonstrate if patient outcomes are improved by 
the early commencement of exercise during a period of 
critical illness.
Early clinical studies in the field have demonstrated 
potential for in-bed cycling interventions (with and 
without FES) to improve physical and cognitive function 
among patients with critical illness.8 9 There are currently 
no published RCTs investigating the effectiveness of 
in-bed cycling in patients with critical illness requiring 
prolonged mechanical ventilation on quadriceps struc-
ture, ICUAW and cognitive outcomes. Consequently, 
further investigation of the effect of in-bed cycling on 
muscle structure, physical function and cognitive func-
tion is warranted.
objectives
The objectives of this study are to:
1. examine whether in-bed cycling in addition to usual 
care is effective in reducing the rate of rectus femoris 
cross-sectional area (CSA) atrophy and ICUAW in 
patients requiring more than 48 hours of invasive 
mechanical ventilation compared with usual care;
2. investigate if in-bed cycling in addition to usual care 
is associated with better functional and cognitive 
outcomes in patients predicted to require more than 
48 hours of invasive mechanical ventilation compared 
with usual care.
MEthods
study design and setting
This trial will be a two-arm, parallel RCT with individual 
participant allocation and blinding of the primary 
outcome assessor. It will be conducted in a 25-bed tertiary 
mixed medical and surgical adult intensive care unit 
(ICU) in Brisbane, Australia. Participants will be allo-
cated 1:1 to receive either usual care or in-bed cycling in 
addition to usual care (figure 1). In designing this study, 
the1 SPIRIT 2013 Checklist was used to ensure that all 
recommended items in a clinical trial were addressed.12
consent
It is anticipated that most patients who are eligible to 
participate in this study in the ICU setting will not be 
able to provide informed consent at the time of study 
enrolment. For those patients who may have the capacity 
to provide informed consent, the Richmond Agitation 
and Sedation Scale (RASS) will be used to determine if 
a patient is rated 'Alert and Calm'. If a patient is rated 
as 'Alert and Calm' on the RASS, the Confusion Assess-
ment Method for the Intensive Care Unit (CAM-ICU) 
will be used to determine if a patient has had delirium 
within the preceding 24 hours. Provided a patient passes 
the RASS and CAM-ICU assessments, the treating clin-
ical team will be approached to determine if the patient 
has the capacity to provide informed consent. Patients 
without delirium for the preceding 24 hours and deemed 
to have capacity will be approached to provide their own 
written informed consent for study participation. For 
eligible patients considered unable to provide informed 
consent at the time of study enrolment, substitute 
decision-makers (family members or next of kin) will 
be approached for written informed consent. The 
Queensland Civil and Administrative Tribunal (QCAT) 
has approved an application to provide consent for indi-
viduals who are unable to give consent and do not have 
a next of kin who is accessible to request consent on the 
patients’ behalf. Delayed consent from the patient will 
be sought once they can provide consent for themselves 
if they are enrolled using QCAT approval. Participation 
in the study is voluntary. Patients or their substitute deci-
sion-makers are able to withdraw at any time without any 
negative consequences on the care they would receive, 
their ongoing relationship with the hospital, or staff 
involved in their care.
The substitute decision-maker consent form (PICF_
SDM_CYCLIST_V3.0_20160701) is attached as an 
online supplementary file 1.
randomisation
Patients will be individually randomised in a 1:1 ratio 
to either intervention or usual care group. Blocking 
(random block sizes) will be used to help balance the 
groups. An investigator not involved in the screening, 
consenting, allocation or assessment processes will use 
computerised random number generation to create the 
randomisation sequence. A randomisation sequence will 
be uploaded onto the Research Electronic Data Capture 
(REDCap) secure web-based computer application.13 The 
REDCap randomisation module will reveal the group 
allocation of each patient to the intervention coordinator 
after a patient’s baseline data have been collected.
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Figure 1 Consort diagram giving flow of participants throughout the study. ICU, intensive care unit; n, number.
Table 1 Inclusion and exclusion criteria
Inclusion Exclusion
Expected to require more than 48 hours of invasive mechanical 
ventilation
Pre-existing condition that is likely to impair mobility/
mobility assessment (ie, significant neurological, 
musculoskeletal, cognitive or mental health disorder)
Able to provide consent or have a family member consent on 
their behalf
Neuromuscular disorder or acute primary brain lesion
(ie, traumatic brain injury, intracranial haemorrhage, stroke or 
hypoxic brain injury)
Enrolled into the study within 96 hours of ICU admission Injuries precluding cycle ergometry (ie, spinal/pelvic/lower limb 
orthopaedic injuries/open abdominal wound)
Expected to remain in ICU for more than 48 hours following 
study enrolment
Obesity >135 kg
(MOTOmed Letto 2 maximum rated weight capacity)
Uncontrolled seizures or status epilepticus
Dire prognosis (ie, unlikely to survive the current admission)
Pregnancy
Children and/or young people (ie, <18 years)
ICU, intensive care unit.
Participants
The study aims to recruit 68 participants. Adult patients 
expected to require at least 48 hours of mechanical venti-
lation will be recruited, with the inclusion and exclusion 
criteria listed in table 1. Criteria to guide when to discon-
tinue or not deliver an intervention are listed in box 1. 
Participants can be recruited into the study and baseline 
sonography measures performed if a patient does not 
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box 1 safety guidelines
Active or passive exercise should not be delivered if:
 ► Clinician’s opinion that patient’s condition is unstable
 ► Resting HR<40 or >120 bpm or new arrhythmia
 ► Evidence of coronary ischaemia, for example, chest pain or ECG 
changes
 ► MAP<60 or SBP>200 mm Hg
 ► SpO2<90%
 ► RASS≥2
 ► Wounds of leg, pelvis or lumbar spine precluding cycle ergometry
 ► Evidence of active bleeding or coagulation disorder: INR>1.8, 
PLT<50 000/µL*
 ► Femoral vascular access†,  for example, dialysis catheter, IABP, 
ECMO or lower limb arterial line‡
 ► Acute DVT or PE
Active exercise should not be delivered if:
 ► >20 µg/min of norepinephrine or comparable inotropic or 
vasopressor support
 ► FiO2>0.55 or PEEP>10 cmH2O
 ► RR>30 with adequate ventilatory support
 ► Temperature >39°C
Stopping criteria: active or passive exercise should cease if:
 ► HR<50 or  >140 bpm, or new arrhythmia develops (including 
ventricular ectopic or new-onset AF)
 ► Evidence of coronary ischaemia, for example, chest pain or ECG 
changes
 ► MAP<60 mm Hg
 ► SBP>200 mm Hg
 ► Clinical signs of cardiorespiratory distress
 ► SpO2<90% for more than 1 min
 ► Patient's request to stop therapy
*Values outside this range would be tolerated if patient is therapeutically 
anticoagulated.
†Other than femoral central line.
‡If a femoral vascular access is inserted unilaterally the contralateral leg may 
be cycled unilaterally.
AF, atrial fibrillation; bpm, beats per minute; DVT, deep vein thrombosis; ECMO, 
extracorporeal membrane oxygenation; FiO2, fraction of inspired oxygen; HR, 
heart rate; IABP, intra-aortic balloon pump; INR, international normalised ratio; 
MAP, mean arterial pressure; PE, pulmonary embolism; PEEP, positive end 
expiratory pressure; PLT, platelets; RASS, Richmond Agitation Sedation Score; 
RR, respiratory rate; SBP, systolic blood pressure; SpO2, saturation of peripheral 
oxygen.
currently meet the in-bed cycling safety criteria in box 1 
(but are considered by their treating clinical team to be 
likely to meet the criteria within their stay in ICU).
study intervention
All study patients will receive usual physiotherapy inter-
ventions while in intensive care. Physiotherapy interven-
tions will include (but are not limited to): respiratory 
physiotherapy, physical rehabilitation exercise interven-
tions including sitting on the edge of the bed, sit to stand 
transfers, sitting out of bed and walking. Usual care phys-
iotherapy interventions will be prioritised over the in-bed 
cycling intervention. Safety guidelines (see box 1) will be 
used to determine if the intervention group patients are 
able to complete an additional daily 30 min progressive 
lower limb in-bed cycling using a bedside cycle ergometer 
(MOTOmed Letto 2). The lead physiotherapist (MRN) 
who has over 10 years of experience in rehabilitative 
exercise with patients with critical illness will primarily 
conduct the majority of in-bed cycling sessions. He has 
been trained by industry cycle ergometry representatives 
and has over 5 years of experience conducting in-bed 
cycling sessions with patients with critical illness. Experi-
enced ICU physiotherapists trained in conducting in-bed 
cycling sessions may conduct the in-bed cycling sessions if 
the lead physiotherapist is unavailable. During the in-bed 
cycling exercise interventions, the patients’ vital signs will 
be monitored. If the intervention group patients are in 
a state of low arousal or sedated, they will cycle continu-
ously and passively at the default passive speed of the cycle 
ergometer (20 revolutions per minute) for 30 min. When 
the participant is following commands, the clinician 
will verbally encourage the patient to complete in-bed 
cycling sessions actively for a duration of 30 min. Once 
the patient can cycle actively, the resistance applied by 
the cycle ergometer will be adjusted to facilitate patient 
intensity between 3 and 5 using the visual Borg scale rate 
of perceived exertion (category ratio 10),14 within the 
specified safety guidelines. An exercise intensity of 3–5 on 
the Borg rate of perceived exertion scale has been shown 
to be safe and feasible with patients with critical illness.15 
This will enable the patient to cycle in-bed either passively 
or actively with assistance from the cycle ergometer. If a 
patient unexpectedly commences active cycling, the addi-
tional active in-bed cycling safety criteria will become rele-
vant. If the patients are deemed unsuitable to continue 
active in-bed cycling, they will be asked to resume passive 
cycling. If the patient continues to actively cycle, the 
session will be ceased. The in-bed cycling sessions will 
continue until the patient completes a minimum of five 
in-bed cycling sessions, unless the patient is discharged 
from hospital prior to completing five sessions. The 
intervention will continue in the acute hospital ward if 
the patient is discharged from ICU prior to completing 
five in-bed cycling sessions. While the patient remains in 
ICU, in-bed cycling sessions will continue (up to 7 days/
week), up to 28 days post-ICU admission. This frequency 
is congruent with usual physiotherapy services that can 
provide rehabilitative exercise interventions to ICU 
patients up to 7 days/week. Patients randomised to the 
usual care arm do not routinely complete in-bed cycling 
sessions during their hospitalisation. Any deviations 
from the planned protocol will be recorded to enable 
appropriate intervention description and, if indicated, a 
per-protocol analysis (in addition to the primary inten-
tion-to-treat analysis).
Participants will not be coerced to complete any 
intervention or outcome measure. Participants may be 
discharged home from the participating acute hospital 
before they have completed outcome measures at each 
assessment time point. If this occurs, participants will be 
asked to return to the hospital to enable the remaining 
outcome measures to be completed and expenses related 
to taxi or parking costs will be reimbursed.
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Table 2 Descriptions of outcome measures for CYCLIST RCT
Assessment component Outcome measure Description
Muscle morphology Ultrasound RF CSA, AP thickness of RF and VI. Measured in triplicate on right 
anterior thigh one-third distance from superior patella to ASIS. 
Patient positioned in supine, 30º head elevation27
Muscle strength MRC sum score Standardised sum of 12 MMTs, 3 MMTs per limb
Score ≤48 indicative of ICU-acquired weakness28
Handgrip strength 
dynamometry
Triplicate bilateral measurement using a Jamar Digital Dynamometer 
(Lafayette) with seated patient29
Physical function ICU Mobility Scale Best level of function achieved in ICU using an 11-point ordinal 
scale30
FSS-ICU Patients’ function measured an 8-point ordinal scale31 32
Functional milestones Time to achieve functional milestones: sit out of bed, time to stand, 
mobilise with assistance and mobilise independently
6 min walk test Submaximal endurance test of distance walked by a patient in 
6 min33
Cognition CAM-ICU Incidence and recorded episodes of acute delirium34
Quality of life EQ-5D-5L EQ-5D-5L35
Intervention acceptability Customised questionnaires Questionnaire about the acceptability of the in-bed cycling 
intervention
AP, anterior posterior; ASIS, anterior superior iliac crest; CAM-ICU, Confusion Assessment Method for the Intensive Care Unit; CSA, cross-
sectional area; CYCLIST, Critical Care Cycling Study; EQ-5D-5L, EuroQol Five Dimensions questionnaire Five Levels scale; FSS-ICU, 
Functional Status Score for the Intensive Care Unit; ICU, intensive care unit; MMT, manual muscle test; MRC, Medical Research Council; RCT, 
randomised controlled trial; RF, rectus femoris; VI, vastus intermedius.
outcomes
Table 2 provides a summary of the outcome measures. 
The primary outcome is the percentage of change in 
rectus femoris CSA measured at baseline (within 24 hours 
of study enrolment) and day 10 (post study enrolment), 
measured by a blinded assessor. The participants will 
be assessed to examine whether there is a between-
group difference in the amount of rectus femoris CSA 
atrophy. The authors anticipate that less rectus femoris 
CSA atrophy will be observed among the in-bed cycling 
group. Day 10 post study enrolment has been chosen as 
the primary endpoint to enable comparison with previ-
ously published data on acute skeletal muscle wasting in 
patients with critical illness and consistent with this previ-
ously reported time frame of observed muscle wasting.1 
Secondary outcome measures in the CYCLIST (Crit-
ical Care Cycling Study) are muscle strength, physical 
function, cognition, quality of life and acceptability of 
intervention.
Demographic information such as age, gender and 
diagnostic code will be collected. Illness-related infor-
mation including length of mechanical ventilation, ICU 
length of stay (LOS)/hospital LOS and discharge desti-
nation, illness severity (Acute Physiology and Chronic 
Health Evaluation III,16 Sequential Organ Failure 
Assessment17 score), premorbid comorbidities, neuro-
muscular blockade and sedation medications admin-
istered, nutrition received, cumulative fluid balance, 
patient's height and weight, and body mass index will 
also be collected.
sample size
Based on the repeated measures design, this study will 
have 80% power to detect a between-group difference of 
2.9% on our primary outcome (change in rectus femoris 
CSA) between the intervention and usual care partici-
pants (assuming type I error 0.05, SD of 6%, and with-
in-patient correlation of 0.5 between assessments, and 
after accounting for an up to 20% dropout rate including 
in-hospital mortality). A total of 68 patients (34 in each 
group) will be recruited into the study. With a dropout 
rate of up to 20%, this would represent approximately 27 
participants completing the trial in each group. It is note-
worthy that some of the assumptions for this calculation 
have been made in the absence of prior RCT data. There 
is some risk that the observed trial data may not fit these 
assumptions (eg, discrepancies in SD or within-patient 
correlation between the repeated measures), and the 
power of the study may differ from this a priori sample 
size estimate.
data collection
The study data will be collected at the time points 
summarised in table 3.
The management of study data will be dependent on 
the type of data collected. Baseline data will be entered 
directly into REDCap-designed digital clinical trial work-
flow management software.13 Ultrasound results will be 
uploaded onto the secure hospital-based AGFA IMPAX 
6.5.3.1005 Medical Image Viewer application. In-bed 
cycling session data, physical assessment measures, 
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Table 3 CYCLIST summary of time points of assessments
Baseline Day 3 Day 7 Day 10 ICU discharge
1 week post ICU 
discharge*
3, 6 months’ post 
ICU-admission
Severity of illness
  APACHE III ✓
  SOFA ✓ ✓ ✓ ✓ ✓
Muscle morphology
  Quadriceps 
ultrasonography
✓ ✓ ✓ ✓ ✓
Strength measures
  MRC sum score ✓ ✓
  Handgrip dynamometry ✓ ✓
Physical function measures
  ICU mobility scale ✓
  FSS-ICU ✓
  Functional milestones ✓ ✓ ✓ ✓ ✓ ✓
  6-MWT ✓
Cognition
  CAM-ICU ✓ ✓ ✓ ✓ ✓
Quality of life
  EQ-5D-5L ✓ ✓
Acceptability of intervention
 Participant acceptability ✓†
Patient outcomes
  ICU length of stay ✓
  Hospital length of stay ✓‡
  Acute discharge 
destination
✓‡
  Mortality ✓ ✓‡ ✓
*1-week post-ICU discharge or at acute hospital discharge if sooner.
†At completion of in-bed cycle ergometry sessions.
‡Measured at acute hospital discharge.
6-MWT, 6 min walk test; APACHE, Acute Physiology and Chronic Health Evaluation; CAM-ICU, Confusion Assessment Method for the 
Intensive Care Unit; CYCLIST, Critical Care Cycling Study; EQ-5D-5L, EuroQol Five Dimensions questionnaire Five Levels scale.; FSS-ICU, 
Functional Status Score for the Intensive Care Unit; ICU, intensive care unit; MRC, Medical Research Council; SOFA, Sequential Organ Failure 
Assessment score.
acceptability of in-bed cycling intervention and quality of 
life questionnaires will be recorded initially onto research 
data sheets. All information recorded on data sheets will 
be subsequently entered into the REDCap application.
Assessments of muscle size will be assessed by ultra-
sound and performed by registered postgraduate trained 
sonographers with expertise in musculoskeletal sonog-
raphy. Sonographers will be blinded to patient treatment 
group allocation and will be responsible for analysing and 
scoring all ultrasound images. The study sonographers 
were involved in the development and standardisation of 
the ultrasound procedure prior to the commencement 
of the study.
Assessment of muscle strength and function will be 
completed by cardiorespiratory physiotherapy assessors 
with a minimum of 3 years’ experience at participants’ 
ICU discharge and 7 days post-ICU discharge. These phys-
iotherapists will be blinded to group allocation. The same 
physiotherapists will also assess 6 min walk test distance 
7 days following ICU discharge. The study physiothera-
pists were trained in the standardised assessment of the 
study outcome measures prior to the commencement of 
the study.
A physiotherapist not involved in blinded outcome 
assessment will be responsible for conducting the in-bed 
cycling sessions, and the remaining ‘usual care’ physio-
therapy will be completed by hospital department phys-
iotherapists not involved in the study. Additionally, the 
primary statistician will be blinded to treatment group 
allocation.
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box 2 Planned secondary analyses
 ► Muscle wasting at baseline, day 3, day 7 and 1 week post-ICU 
discharge
 ► Muscle wasting adjusted for number of failing vital organs*
 ► Muscle wasting adjusted for severity of illness on admission to ICU†
 ► Muscle wasting adjusted for the number of days prior to a patient 
commencing active activity
 ► Muscle wasting adjusted for the patients’ cumulative fluid balance 
on the day of the ultrasound scan
 ► Relationship between muscle wasting and participants’ nutritional 
intake while in ICU
 ► Relationship between sedative and paralytic medications and 
muscle wasting
 ► Cost comparison of hospitalisation for both the intervention and 
usual care groups‡




*Sequential Organ Failure Assessment (SOFA).
†APACHE III (Acute Physiology and Chronic Health Evaluation) data.
‡Health service utilisation data.
§Queensland Hospital Admitted Patient Data Collection (QHAPDC).
¶Queensland Health Statistical Services Branch.
ICU, intensive care unit.
To minimise the chances of unintentional unblinding, 
at the beginning of each assessment the blinded assessors 
will clearly state that they wish to complete the assess-
ment process without knowing which group the patient 
was allocated to. If any blinded assessors were to become 
unblinded to group allocation for any patient (eg, 
through inadvertent revelation by a patient being assessed 
or unanticipated exposure to a patient taking part in 
an in-bed cycling session), they have been instructed to 
report this to the intervention coordinator (MRN) who 
will also record when this occurred.
Analysis
Data will be analysed and reported using intention-to-
treat principles (primary analysis). A per-protocol analysis 
will be conducted to assist in determining the efficacy of 
the in-bed cycling protocol if variation from the planned 
protocol occurs for a substantial proportion of patients. 
The per-protocol analysis will include only patients who 
adhered to the protocol and received at least 80% of 
training sessions (minimum of four sessions).
Descriptive statistics and generalised linear mixed 
models (that can adjust for baseline status) will be used 
to examine the effect of group allocation (intervention 
vs usual care) on the primary and secondary outcomes.18 
As this is a randomised trial, we do not plan to adjust for 
potential confounders (eg, age, gender, comorbidities), 
but will compare the characteristics of the sample by 
treatment group and may adjust if a potential confounder 
differs greatly between groups.
If blinded sonographers are unable to complete an 
ultrasound measurement at designated time points, then 
the scan will be performed within a day (±1 day) of the 
designated time point. A subsequent sensitivity anal-
ysis will be conducted to determine if there is a differ-
ence by measurement timing. If the primary outcome 
cannot be collected by a sonographer within the speci-
fied time frame, a physiotherapist experienced in muscu-
loskeletal ultrasound will measure thigh muscle size. 
The measurement will be from the most anterior aspect 
of rectus femoris to the anterior surface of the femur. 
This will assist in the imputation of the missing primary 
outcome data. Statistical analysis of available data will be 
used for the primary analysis when data are completely 
missing. Multiple imputation will be conducted if more 
than 20% of outcome data are missing. Additional 
planned secondary analyses are listed in box 2. The prin-
cipal investigators will determine if study protocol modifi-
cations are required and any modifications to the existing 
protocol will be declared.
trial management
The principal investigator (MRN) will oversee the 
conduct and progress of the trial. The principal investi-
gator will screen the daily admission to ICU lists and liaise 
with the treating medical teams to optimise participant 
enrolment. No interim analyses are planned. The prin-
cipal investigator will ensure all research personnel are 
appropriately orientated and trained, oversee recruit-
ment and report to a trial safety monitoring committee 
who will monitor the progress and conduct of the trial. 
The trial safety monitoring committee will include: a 
physiotherapist and researcher experienced in the safe 
conduct of clinical trials with physiotherapy interven-
tions; the trial coordinator and principal investigator; 
a critical care nurse who is also experienced in the safe 
conduct of clinical trials in critical care settings; and 
two ICU medical consultants experienced with the 
safe conduct of clinical trials in ICUs. One of the ICU 
medical consultants is employed externally to the study 
site. The principal investigator will provide an update 
report to the safety monitoring committee on a monthly 
basis (and additional ad hoc reports if an adverse event 
occurs). Additionally, any serious adverse events will be 
reported to the approving Metro South Human Research 
Ethics Committee that is overseeing the study. During 
in-bed cycling sessions, participants will be monitored for 
adverse events that will be recorded on the session data 
collection form. Adverse events that are being monitored 
for are: line or airway dislodgement, increase in ventila-
tory support that persists longer than 5 min post exercise 
(eg, increase in positive end expiratory pressure or frac-
tion of inspired oxygen), blood oxygen desaturation less 
than 88% for more than 1 min, increase in vasoactive or 
pain relief medication greater than 5 mcg/min, increase 
in systolic blood pressure greater than 180 mm Hg for 
more than 2 min, increase in heart rate greater than 
140 bpm for more than 2 min, decrease in mean arterial 
blood pressure less than 60 mm Hg for greater than 2 min 
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and decrease in heart rate less than 50 bpm for more than 
2 min.
dissemination
Study results will be disseminated via publication in 
peer-reviewed literature and scientific conference presen-
tations. It is anticipated that media releases in lay form 
will be completed to target the general community. 
Study results will also be placed on a university website 
for viewing by participants and other interested parties. 
There are no publication restrictions. Authorship eligi-
bility guidelines as outlined in the Australian Code for 
the Responsible Conduct of Research19 and consistent 
with those proposed by the International Committee of 
Medical Journal Editors will be followed to determine 
authorship.20
dIscussIon
Survival rates following critical illness are improving21; 
however, patients are experiencing deficits in physical and 
cognitive function that do not equal age-matched peers 
5 years after an episode of critical illness.22 The delayed 
initiation of rehabilitative exercise interventions with 
patients with critical illness may explain the limited effec-
tiveness of clinical trials that have studied the effect of 
exercise interventions on patients’ functional outcomes.11 
A binational clinical trial that aimed to commence exer-
cise interventions as early as possible with mechanically 
ventilated patients reported that despite the presence 
of a dedicated early mobility team, patient mobilisation 
out of bed while mechanical ventilation was in situ was 
rare.23 These results are substantiated by point prevalence 
studies from Australia, New Zealand and Germany that 
report that in 1281 patient days only one patient with an 
endotracheal tube was mobilised out of bed.3 24 The pres-
ence of an endotracheal tube is negatively correlated with 
out-of-bed mobilisation in the USA with a reported OR 
of 0.1 (95% CI 0.05 to 0.2).25 Studies have reported that 
following a period of critical illness, rehabilitative inter-
ventions do not hasten recovery when they are provided 
after acute hospital discharge.15 26 Consequently, this trial 
will provide valuable clinical trial evidence regarding the 
effect of an exercise intervention initiated early in the 
illness of patients with critical illness. Specifically, it will 
report empirical data about the effect of the intervention 
on the rate of skeletal muscle wasting, and whether early 
exercise interventions that can be feasibly implemented 
among people who are mechanically ventilated are associ-
ated with improved physical, cognitive and health-related 
quality of life outcomes.
CYCLIST is a phase IIb RCT that is powered to investi-
gate if the early application of an additional in-bed cycling 
intervention is able to reduce the rate of skeletal muscle 
atrophy of patients’ quadriceps muscle during and imme-
diately following a period of critical illness, in compar-
ison to usual care. Secondary outcomes evaluated in this 
study will assist sample size calculations for future studies 
to assess for efficacy of functional outcomes. The study 
will also aid planning of future rehabilitation-based clin-
ical trials with regard to rate of participant recruitment. 
The investigators are planning to meet at the comple-
tion of the study to facilitate reflection on aspects of the 
study that could be improved and to consider whether a 
definitive phase III RCT is warranted. This will include 
consideration of the evidence of effect on primary and 
secondary outcomes, participant recruitment and adher-
ence to the in-bed cycling protocol and rate, as well as 
acceptability of the intervention.
The strengths of this study are the implementation 
of the in-bed cycling intervention as soon as feasible 
(including while patients are still mechanically venti-
lated), with clear commencement and stopping rules. 
Another strength of the study is the blinded assessment 
of muscle structure, strength and function assessments. 
Measurement of the effect of early in-bed cycling on 
quality of life up to six months post ICU-admission is 
another strength that will assist to demonstrate if potential 
gains made early during a period of critical illness corre-
spond to lasting functional improvements. It is expected 
that this study will also provide insights regarding the 
feasibility of the in-bed cycling intervention with patients 
with critical illness from the rates of compliance and 
completion of the in-bed cycling exercise intervention. 
The acceptability of in-bed cycling intervention from the 
perspective of patients with critical illness will be sought 
through a questionnaire and provide new information to 
inform potential implementation strategies for this inter-
vention. A potential limitation of the study may be diffi-
culty completing functional assessment measures at ICU 
discharge and at 1 week post-ICU discharge with patients 
who are either profoundly weak or present with an acute 
cognitive dysfunction. Further, usual care physiotherapy 
interventions will be delivered by treating teams inde-
pendent of the study and prioritised over in-bed cycling. 
The frequency, intensity, type and duration of all usual 
care physiotherapy interventions are not being prospec-
tively recorded as part of the trial outcomes. As the study 
design is an RCT, it is anticipated that the usual care phys-
iotherapy will be similar across groups. Also this study is 
being conducted at a single centre and therefore results 
may need to be interpreted with caution.
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